Pharmaust Limited (AU:PAA) has released an update.
Pharmaust Limited has announced the appointment of Dr. Michael Thurn as a director effective May 31, 2024. Dr. Thurn holds a substantial interest in the company, with 2.9 million shares and options, but is not the registered holder of these securities. His interest comes from being a beneficiary of the Thurn Family Account, which holds these investments.
For further insights into AU:PAA stock, check out TipRanks’ Stock Analysis page.
